Steve served as a Venture Partner of S3 Ventures for over 10 years (from founding in 2005 through 2015). Steve is a pioneer in venture capital. He began his distinctive career by backing legendary venture capital firm Kleiner Perkins and co-investing in several of their outstanding companies — such as Genentech, Hybritech and Tandem — while serving as vice president of venture capital at The Hillman Company.
Steve is also a pioneer in the life sciences. In 1988, he became president of BCM Technologies (“BCMT”), where he was involved in the formation of more than 30 new technology companies spun out of the Baylor College of Medicine (“BCM”), including: Lexicon (LEXG), GeneMedicine (VLTS), ForeFront (SKIL), Triplex (AGEN), PrimaCis (MDLIQ) and Zonagen (ZONA). He also established BCMT’s venture fund and led BCMT’s venture advisory board, consisting of prominent investors such as Oxford Biosciences, Domain Associates, Versant, VenRock, EuclidSR, ARCH, J&J Development and Polaris.
Steve is the recipient of the 2012 Dai-Shan Wong Memorial Achievement Award from Gulf Coast Medical Device Manufacturers. This annual award is presented to the person who exemplifies the same spirit and enthusiasm as that of Dia-Shan Wong. Mr. Wong was dedicated to the growth and regulatory education of Houston’s life science community.
Steve earned a BS in physics from the Massachusetts’ Institute of Technology (MIT) and an MBA from the Harvard Business School. He taught a graduate venture capital course at Rice University during the years 1992 to 2005.